Literature DB >> 24637128

Hyposmia and cardiovascular dysautonomia correlatively appear in early-stage Parkinson's disease.

Yasuaki Mizutani1, Tomohiko Nakamura2, Akinori Okada1, Junichiro Suzuki1, Hirohisa Watanabe1, Masaaki Hirayama3, Gen Sobue4.   

Abstract

OBJECTIVE: Olfactory dysfunction is considered to precede motor symptoms and early markers of Parkinson's disease (PD), while the relative time at which cardiovascular dysautonomia appears in PD is not well understood. To assess the appearance of cardiovascular dysautonomia in PD, we evaluated its relation to olfactory dysfunction in early-stage PD patients.
METHODS: Twenty-three non-demented PD patients within 2 years from the onset of motor symptoms were enrolled. We evaluated olfactory dysfunction by the Odor Stick Identification Test for Japanese (OSIT-J) and analyzed its relationship to the results of other cardiovascular autonomic tests and cardiac (123)I-metaiodobenzylguanidine (MIBG) scintigraphy.
RESULTS: There was a correlation between olfactory scores and increased blood pressure in both the norepinephrine (r = 0.75, p < 0.0001, n = 21) and dobutamine (r = 0.57, p = 0.0087, n = 20) infusion tests and cardiac MIBG uptake (r = 0.42, p = 0.049, n = 23). The fall in orthostatic blood pressure during the head-up tilt test was not correlated with the olfactory scores, but the Valsalva maneuver revealed that OSIT-J scores correlated with the pressure recovery time from phase III to the return of blood pressure to baseline (r = 0.54, p = 0.037, n = 15) and with the magnitude of blood pressure overshoot during phase IV (r = 0.67, p = 0.0016, n = 20).
CONCLUSION: Our results demonstrate that extensive components of the cardiovascular sympathetic system as well as the olfactory system are correlatively impaired in the early stage of PD, suggesting that degeneration of broad aspects of the cardiovascular sympathetic system occurs concurrently with olfactory system degeneration during the premotor phase of PD.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardiac (123)I-metaiodobenzylguanidine scintigraphy; Cardiovascular dysautonomia; OSIT-J; Olfactory dysfunction; Parkinson's disease

Mesh:

Substances:

Year:  2014        PMID: 24637128     DOI: 10.1016/j.parkreldis.2014.02.010

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  9 in total

Review 1.  Olfactory dysfunction in dementia.

Authors:  Jorge Alves; Agavni Petrosyan; Rosana Magalhães
Journal:  World J Clin Cases       Date:  2014-11-16       Impact factor: 1.337

2.  Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.

Authors:  Hiroaki Fujita; Keisuke Suzuki; Ayaka Numao; Yuji Watanabe; Tomoyuki Uchiyama; Tomoyuki Miyamoto; Masayuki Miyamoto; Koichi Hirata
Journal:  PLoS One       Date:  2016-11-03       Impact factor: 3.240

3.  Pattern of Reduced Functional Connectivity and Structural Abnormalities in Parkinson's Disease: An Exploratory Study.

Authors:  Rachel Paes Guimarães; Maria Cristina Arci Santos; Alain Dagher; Lidiane Soares Campos; Paula Azevedo; Luiza Gonzaga Piovesana; Brunno Machado De Campos; Kevin Larcher; Yashar Zeighami; Augusto C Scarparo Amato-Filho; Fernando Cendes; Anelyssa Cysne Frota D'Abreu
Journal:  Front Neurol       Date:  2017-01-13       Impact factor: 4.003

Review 4.  Optimizing Parkinson's disease diagnosis: the role of a dual nuclear imaging algorithm.

Authors:  J William Langston; Jesse C Wiley; Michele Tagliati
Journal:  NPJ Parkinsons Dis       Date:  2018-02-23

5.  Association between changes in visual evoked magnetic fields and non-motor features in Parkinson's disease.

Authors:  Yoshiro Fujisawa; Tomomi Minato; Jun-Ichi Uemura; Minoru Hoshiyama; Hirohisa Watanabe; Masaaki Hirayama
Journal:  Nagoya J Med Sci       Date:  2017-02       Impact factor: 1.131

6.  Ultrasonication-based rapid amplification of α-synuclein aggregates in cerebrospinal fluid.

Authors:  Keita Kakuda; Kensuke Ikenaka; Katsuya Araki; Masatomo So; César Aguirre; Yuta Kajiyama; Kuni Konaka; Kentaro Noi; Kousuke Baba; Hiroshi Tsuda; Seiichi Nagano; Takuma Ohmichi; Yoshitaka Nagai; Takahiko Tokuda; Omar M A El-Agnaf; Hirotsugu Ogi; Yuji Goto; Hideki Mochizuki
Journal:  Sci Rep       Date:  2019-04-12       Impact factor: 4.379

7.  Association between autonomic dysfunction and olfactory dysfunction in Parkinson's disease in southern Chinese.

Authors:  Xin-Yi Wang; Ying-Ying Han; Gang Li; Bei Zhang
Journal:  BMC Neurol       Date:  2019-02-02       Impact factor: 2.474

8.  Microstructural network alterations of olfactory dysfunction in newly diagnosed Parkinson's disease.

Authors:  Ming-Ching Wen; Zheyu Xu; Zhonghao Lu; Ling Ling Chan; Eng King Tan; Louis C S Tan
Journal:  Sci Rep       Date:  2017-10-02       Impact factor: 4.379

9.  Odor selectivity of hyposmia and cognitive impairment in patients with Parkinson's disease.

Authors:  Cheng-Jie Mao; Fen Wang; Ju-Ping Chen; Ya-Ping Yang; Jing Chen; Juan-Ying Huang; Chun-Feng Liu
Journal:  Clin Interv Aging       Date:  2017-10-09       Impact factor: 4.458

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.